Moreover, serum ALT, AST, and GGT levels in NAFLD patients with SEMA7A heterozygous mutations were also higher than in the paired controls (P = 0.023, P = 0.100, and P = 0.345, respectively) (Table 2). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.